Three-year follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, for second-line (2L) treatment of non-small cell lung cancer (NSCLC)
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Paz-Ares, L.
Kim, T. M.
Vicente, D.
Felip, E.
Lee, D. H.
Lee, K. H.
Lin, C-C.
Flor, M. J.
Di Nicola, M.
Alvarez, R. M.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier